Navigation Links
Drug Approved to Curb Alcohol Dependency

A study of alcoholics has revealed that of the two drugs approved for curbing alcoholics' cravings, naltrexone, proved to be little more beneficial than specialized counseling. // However the second drug, acamprosate, on the market was not better than a placebo.

Naltrexone, was sold generically in daily pill form under the brand name,ReVia by Barr Pharmaceuticals Inc., while acamprosate was, marketed under the brand name Campral by Forest Laboratories Inc.

According to lead author of the research, Dr. Raymond Anton, of the Medical University of South Carolina in Charleston who said ‘We were surprised by two findings from our study. One was that acamprosate was no more effective than placebo alone and two, that while naltrexone was effective in its own right, combining it with the specialized counseling added no more effectiveness than naltrexone by itself.’

In effect people could either choose to take naltrexone or to see a specialized counselor who could counsel them about the prevention of a relapse, and dealing with their alcohol addiction.

Naltrexone acts on opiate receptors while acamprosate has its effect on a neurotransmitter. They both have been approved by Food and Drug Administration approval. Naltrexone, made by Alkermes Inc. as an injectable form, to be taken monthly, will be marketed by Cephalon Inc.

The results of the study have been published in the Journal of the American Medical Association.

According to their estimates there are 8 million alcoholics in the United States.

1,400 alcohol-dependent patients who wanted to stop drinking were the participants of the study. They were divided into groups and treated for 16 weeks.

Some of the participants received drugs, while some received a placebo, and some no pills at all. Besides this most subjects were also medically managed by encouraging them to abstain from alcohol and consistently take their medicatio n. In addition some participants underwent specialized behavioral therapy.

The research evaluated relapses of consumption of several drinks in a day for up to a year.

It was found that subjects who took naltrexone and received management had the highest percentage of days of abstinence. Participants who underwent behavioral treatment in addition to a placebo did just as well.

Following this Anton said ‘This study and others have shown that people should be optimistic about treatment for their alcohol problems, that treatment does work.’

'"/>




Related medicine news :

1. Levothyroxine Thyroid Hormone Replacement, Approved for Hypothyroidism
2. New FDA Approved Drug To Treat Migraine
3. New FDA Approved Drug NATRECOR For Heart Failure Patients
4. New Oral Rinse For Gingivitis Approved By FDA
5. Child Friendly Zidovudine Preparation for treating HIV infection Approved By The FDA
6. AIDS Generic Drugs Approved by FDA for Sale in US
7. FDA Approved Nerve-Stimulation Therapy Now Available In New York
8. Revlimid Approved For Treatment Of Myelodysplastic Syndrome (MDS) by FDA
9. Pfizer’s Eraxis Approved By The FD
10. Inhalers for Kids Was Approved By the FDA
11. Alcoholism Drug Vivitrol Approved By FDA
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader in healthcare ... Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during ... , The annual award competition recognizes editorial and design excellence across a range of ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the Health ... Miles by Moonlight to raise money for the American Heart Association Heart Walk. Teams ... Teams will work together to keep their treadmills moving for 5 hours. Treadmills will ...
(Date:10/12/2017)... ... ... Health Literacy Innovations (HLI), creator of the Health Literacy ... Patient Education Network (CPEN), an independent professional organization that shares best practices in ... , As CPEN’s strategic partner, HLI will help support CPEN members by sharing ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... the latest in wound care advancements to physician colleagues, skilled nursing facility medical ... titled, "Navigating the Treacherous Waters of Wound Care." , "At many of these ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... 2, 2017 The Rebound mobile app is poised ... reverse the tide of prescription drug addiction. The app empowers ... intake and stepping down their dosage in a safe, controlled ... December 2017; the first 100,000 people to sign up will ... http://www.rebound-solution.com/ ...
(Date:9/27/2017)... CAESAREA, Israel and NEW YORK , Sept. ... company with mobile health and big data solutions, today announced that its ... today. Please check your local TV listings for when The Dr. Oz ... ... ninth season this month. ...
(Date:9/22/2017)... , Sept. 22, 2017  As the latest Obamacare ... Bill Cassidy (R-LA) and Lindsey Graham ... that the medical device industry is in an odd ... tax, the 2.3% excise tax on medical device sales ... also want covered patients, increased visits and hospital customers ...
Breaking Medicine Technology: